Theranostics and Precision Medicine for the Management of Hepatocellular Carcinoma: Translational and Clinical Outcomes, Volume Three provides comprehensive information about ongoing research and clinical data on liver cancer. The book presents detailed descriptions about diagnostics and therapeutic options for easy understanding, with a focus on precision medicine approaches to improve treatment outcomes. This updated volume discusses topics such as clinical and safety assessment of HCC patients, liver transplantation as a therapeutic option, immunotherapy interventions, and image-based surveillance. In addition, it discusses immunohistology of HCC-enabled precision medicine and artificial intelligence for hepatocellular carcinomas.
This is a valuable resource for cancer researchers, oncologists, graduate students, hepathologists and members of biomedical research who need to understand more about liver cancer to apply in their research work or clinical setting.
1. Title of Book - p. i 2. Cover image - p. i 3. Title page - p. ii 4. Table of Contents - p. iii 5. Copyright - p. iv 6. Dedication - p. v 7. List of contributors - p. xv 8. About the editors - p. xix 9. Preface - p. xxi 10. Chapter 1. Nanoparticles for diagnosis and treatment of hepatocellular carcinoma - p. 1 11. Chapter 2. Theranostics application of nanocarriers in hepatocellular carcinoma - p. 15 12. Chapter 3. Nanoparticle-based theranostics and their role in hepatocellular carcinoma - p. 29 13. Chapter 4. Therapeutic options for the management of hepatocellular carcinoma - p. 43 14. Chapter 5. Targeting hepatocellular carcinoma by small-molecule inhibitors - p. 63 15. Chapter 6. Curing of liver cancer: an update on the efficacy of bioactive compounds - p. 81 16. Chapter 7. Plant therapeutics for hepatocellular carcinoma - p. 93 17. Chapter 8. Phytochemicals for hepatocellular carcinoma therapy: from in vitro to clinic - p. 109 18. Chapter 9. Resveratrol for hepatocellular carcinoma therapy - p. 133 19. Chapter 10. Curcumin: a spice pigment against hepatic cancer - p. 141 20. Chapter 11. Curcumin formulated nanoparticles for hepatocellular carcinoma - p. 161 21. Chapter 12. Role of phytoconstituents in the hepatocellular carcinoma management: current perspective, challenges, and future perspectives - p. 175 22. Chapter 13. Phytonanoformulations for hepatocellular carcinoma therapy - p. 197 23. Chapter 14. Immune checkpoint inhibitors for hepatocellular carcinoma - p. 215 24. Chapter 15. Recent advancements in immunotherapy interventions for the management of liver cancer - p. 225 25. Chapter 16. Immunotherapy for hepatocellular cancer: a review of current status - p. 245 26. Chapter 17. Updates on clinical trials for the management of hepatocellular carcinoma - p. 259 27. Chapter 18. Theranostic and precision medicine for the diagnosis of hepatocellular carcinoma - p. 275 28. Chapter 19. Precision medicine approaches for treating hepatocellular carcinoma - p. 287 29. Chapter 20. Decoding the functional role of extracellular vesicles in hepatocellular carcinoma: implications in clinical theranostics - p. 301 30. Chapter 21. Cathepsin B: structure, function, tumorigenesis, and prognostic value in hepatocellular carcinoma - p. 341 31. Chapter 22. Chemotherapy for hepatocellular carcinoma—an updated review - p. 351 32. Chapter 23. Recent advances in medical treatment of hepatocellular cancer - p. 365 33. Chapter 24. Recent perspectives on therapeutic significance of microRNAs in hepatocellular carcinoma - p. 377 34. Chapter 25. Pharmacogenomics and outcomes for hepatocellular cancer treatment - p. 401 35. Chapter 26. Epigenetic biomarkers in diagnosis, prognosis, and treatment of hepatocellular carcinoma - p. 415 36. Index - p. 435
Theranostics and Precision Medicine for the Management of Hepatocellular Carcinoma: Translational and Clinical Outcomes, Volume Three provides comprehensive information about ongoing research and clinical data on liver cancer. The book presents detailed descriptions about diagnostics and therapeutic options for easy understanding, with a focus on precision medicine approaches to improve treatment outcomes. This updated volume discusses topics such as clinical and safety assessment of HCC patients, liver transplantation as a therapeutic option, immunotherapy interventions, and image-based surveillance. In addition, it discusses immunohistology of HCC-enabled precision medicine and artificial intelligence for hepatocellular carcinomas.
This is a valuable resource for cancer researchers, oncologists, graduate students, hepathologists and members of biomedical research who need to understand more about liver cancer to apply in their research work or clinical setting.
1. Title of Book - p. i 2. Cover image - p. i 3. Title page - p. ii 4. Table of Contents - p. iii 5. Copyright - p. iv 6. Dedication - p. v 7. List of contributors - p. xv 8. About the editors - p. xix 9. Preface - p. xxi 10. Chapter 1. Nanoparticles for diagnosis and treatment of hepatocellular carcinoma - p. 1 11. Chapter 2. Theranostics application of nanocarriers in hepatocellular carcinoma - p. 15 12. Chapter 3. Nanoparticle-based theranostics and their role in hepatocellular carcinoma - p. 29 13. Chapter 4. Therapeutic options for the management of hepatocellular carcinoma - p. 43 14. Chapter 5. Targeting hepatocellular carcinoma by small-molecule inhibitors - p. 63 15. Chapter 6. Curing of liver cancer: an update on the efficacy of bioactive compounds - p. 81 16. Chapter 7. Plant therapeutics for hepatocellular carcinoma - p. 93 17. Chapter 8. Phytochemicals for hepatocellular carcinoma therapy: from in vitro to clinic - p. 109 18. Chapter 9. Resveratrol for hepatocellular carcinoma therapy - p. 133 19. Chapter 10. Curcumin: a spice pigment against hepatic cancer - p. 141 20. Chapter 11. Curcumin formulated nanoparticles for hepatocellular carcinoma - p. 161 21. Chapter 12. Role of phytoconstituents in the hepatocellular carcinoma management: current perspective, challenges, and future perspectives - p. 175 22. Chapter 13. Phytonanoformulations for hepatocellular carcinoma therapy - p. 197 23. Chapter 14. Immune checkpoint inhibitors for hepatocellular carcinoma - p. 215 24. Chapter 15. Recent advancements in immunotherapy interventions for the management of liver cancer - p. 225 25. Chapter 16. Immunotherapy for hepatocellular cancer: a review of current status - p. 245 26. Chapter 17. Updates on clinical trials for the management of hepatocellular carcinoma - p. 259 27. Chapter 18. Theranostic and precision medicine for the diagnosis of hepatocellular carcinoma - p. 275 28. Chapter 19. Precision medicine approaches for treating hepatocellular carcinoma - p. 287 29. Chapter 20. Decoding the functional role of extracellular vesicles in hepatocellular carcinoma: implications in clinical theranostics - p. 301 30. Chapter 21. Cathepsin B: structure, function, tumorigenesis, and prognostic value in hepatocellular carcinoma - p. 341 31. Chapter 22. Chemotherapy for hepatocellular carcinoma—an updated review - p. 351 32. Chapter 23. Recent advances in medical treatment of hepatocellular cancer - p. 365 33. Chapter 24. Recent perspectives on therapeutic significance of microRNAs in hepatocellular carcinoma - p. 377 34. Chapter 25. Pharmacogenomics and outcomes for hepatocellular cancer treatment - p. 401 35. Chapter 26. Epigenetic biomarkers in diagnosis, prognosis, and treatment of hepatocellular carcinoma - p. 415 36. Index - p. 435
